Thomas Steyer’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Thomas Steyer’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,523,000	Closed	-$58.5M	–	189
2023 Q2	$58.5M	Buy	+1,523,000	New	+$39.1M	0.29%	64

Thomas Steyer's KDNY Position: Q3 2023 in Review

Thomas Steyer sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 1,523,000 shares — an estimated $58.5M sold.

Thomas Steyer first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $58.5M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Thomas Steyer reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Thomas Steyer sold 1,523,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $58.5M.
Thomas Steyer first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Thomas Steyer's Chinook Therapeutics, Inc. Common Stock position peaked at $58.5M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.